The U.S. Department of Homeland Security (DHS) has been actively engaged in combating the trafficking of illicit fentanyl, with seizures of the dangerous synthetic opioid, its precursor chemicals, and pill-making equipment totaling almost 460,000 pounds and 10,000 pieces of equipment between fiscal years 2021 and 2024. These efforts are primarily carried out by U.S. Customs and Border Protection (CBP) and Homeland Security Investigations (HSI), a component of U.S. Immigration and Customs Enforcement. CBP focuses on inspecting individuals and shipments crossing the border and conducting patrols, while HSI investigates criminal organizations and individuals involved in illicit activities. Both agencies also collaborate on special operations to disrupt supply chains and work with domestic and international law enforcement partners.
Article continues after these messages…
While other outlets focus on getting quotes from politicians who don't even live in our congressional district, we're focused on providing the hard-hitting truths and facts without political spin. We don't lock our news behind a paywall, will you help us keep it that way? If you're tired of news sweetened with confirmation bias, consider becoming a monthly supporter. But if you're not, that's fine too—we're confident in our mission and will be here if you decide you're ready for the truth. Just $5/month helps fund our local reporting, live election night coverage, and more.
Become a paid supporter for reduced ad experience!
Despite these significant seizure numbers and ongoing operations, a review by the U.S. Government Accountability Office (GAO) has identified limitations in DHS’s ability to comprehensively assess the effectiveness of its strategies to combat fentanyl trafficking. The GAO’s findings indicate that DHS has not yet established a program mandated by law to collect specific data and develop metrics for evaluating the success of its anti-fentanyl efforts. This legal requirement, part of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, aims to ensure a structured approach to monitoring progress in deterring the flow of fentanyl, its analogues, and precursor chemicals into the United States.
The responsibility for creating this program was assigned to CBP, but the agency reportedly lacks access to crucial information from other DHS components necessary for its development. Without this unified program and access to comprehensive data, it is challenging for DHS to gauge the true impact and progress of its various initiatives. Furthermore, the GAO noted that DHS has not established clear performance goals and corresponding measures that align with its broader strategic objectives for combating fentanyl trafficking. The establishment of such goals and metrics, potentially through the statutorily required program, would significantly improve DHS’s capacity to measure progress toward its long-term aims. The GAO has recommended that DHS establish the required data collection and assessment program, ensure the responsible entity has access to necessary departmental data, and develop performance goals and measures linked to its strategic objectives. DHS has indicated its agreement with these recommendations.
These ongoing efforts by DHS aim to mitigate the severe impact of fentanyl, which remains a primary driver of overdose deaths in the United States, accounting for an estimated 48,000 deaths in 2024. The success of these measures is crucial for public safety.
Article by Mel Anara, based upon information from U.S. Government Accountability Office
Do you believe we got something wrong? Please read our publishing standards and corrections policy.
Did you know? Supporters get a reduced ad experience!
Sponsored Articles
Get daily and breaking news for Washington County, MD area from Radio Free Hub City. Sign up with your email today!
Paid supporters have a reduced ad experience!
Discover more from Radio Free Hub City
Subscribe to get the latest posts sent to your email.












